Ansamer‐Controlled Bicyclic Peptides as Integrin αvβ6 Targeting Agents

a designed toxin-drug conjugate exhibits remarkable tumor-suppressing effects in vivo. These findings reveal how conformational isomers of ansamers affect biological activity-and highlight their potential for the identification of new bioactive molecules.